Skin Caner
Fernando Vega, M.D. 1
Skin Cancer
Fernando Vega, MDSeattle Healing Arts
Precancerous lesions
Clinical characteristics
Precancerous lesionsCommon skin cancers
Precancerous skin lesionsActinic keratosesActinic keratoses
Dysplastic melanocytic nevi
ACTINIC KERATOSISCommon sun-induced premalignant neoplasm of the epidermis that occurs primarily on exposed skin
Consequence of cumulative qlong-term sun exposure
Prevalence ↑with ↑age
Men > women
Also genetic factors - ↑in fair skin and in genetic syndromes eg xeroderma pigmentosum
NATURAL HISTORY
Some lesions (10%) spontaneously regress
Some (majority) remain unchangedSome (majority) remain unchanged
Others (1-10%) progress and develop into SCC – risk increased with continued sun exposure or concurrent immunosuppression
CLINICAL FEATURESEarliest evidence is a tiny red telangiectatic spot
Then dry, rough and adherent scale
Ski l d/ d/ ll / bSkin coloured/ red/ yellow/ brown
Usually multiple
Lesions on hands and forearms tend to be thicker
Actinic change on lips=actinic chelitis
Associated with other signs of sun damage – solar elastosis, wrinkled skin, solar lentigines
Skin Caner
Fernando Vega, M.D. 2
Actinic keratoses Actinic keratoses
Actinic keratoses and SCC Actinic keratoses and SCC
Actinic keratoses and BCC Actinic keratoses
10% risk of malignant transformation
Skin Caner
Fernando Vega, M.D. 3
Hypertrophic AK’s Actinic cheilitis
Liquid nitrogen cryotherapy
Topical therapies
Treatment of AK’s
5-FU (Efudex)
Imiquimod (Aldara)
Curettage for hypertrophic lesions
Residual hypopigmentation
Liquid nitrogenCryotherapy
Blister formation
Topical therapiesEfudex or Aldara
* 3-5 times per week* 6-8 weeks
Dysplastic nevi
•Precursors for melanoma•When to biopsy
Skin Caner
Fernando Vega, M.D. 4
Biologic Events and Molecular Changes in the Progression of Melanoma
Miller A and Mihm M. N Engl J Med 2006;355:51-65
Clinical Images of Pigmented Lesions
Tsao H et al. N Engl J Med 2004;351:998-1012
Non-melanoma skin cancers
Basal cell carcinoma
Squamous cell carcinomaSquamous cell carcinoma
Keratoacanthoma
Risk factors for development of BCC and SCC
Fair skin (Fitzpatrick’s types I-III)Blue eyesRed hair
Family historyy yGenetic syndromes
Chronic sun exposure
Old age
Arsenic, tar
Basal cell carcinoma
BCC- clinical types
Nodular
SuperficialSuperficial
Morpheaform
Skin Caner
Fernando Vega, M.D. 5
Nodular BCCChronic lesion
Easy bleeding
Pearly border
Surface telangiectasias
Head and neck, trunk, and extremities
Skin Caner
Fernando Vega, M.D. 6
Superficial BCCErythematous scaly plaque
Slow growth
Asymptomatic
Trunk, extremities, face
Superficial BCC Morpheaform BCC
Resembles scar
Asymptomatic and slow growinggrowing
Ill-defined margins
Marked subclinical extension
BCC is the most frequent skin cancer (80%)
BCC is 4x more frequent than SCC
Metastases are rare (<1% of cases)
Local destruction of tissue
Treatment of BCCCurettage electrodessication (ED/C)
Surgical excisionTraditional
95% Cure Rate
Mohs surgery
Radiation therapy
Topical therapyimiquimod
50-75% Cure Rate
Skin Caner
Fernando Vega, M.D. 7
Squamous cell carcinoma
SCC types
In-situBowen’s disease
f QErythroplasia of QueyratInvasive SCCKeratoacanthoma
Bowen’s disease
In-situ SCC
Arsenic HPV 16Arsenic, HPV 16, radiation
Invasive SCC
Erythematous nodule
Indurated lesion
Sun-exposed skinMen > women
Slow growth
Invasive SCC Keratoacanthoma Low grade SCC
Rapid growth over weeks
Trauma, sun exposure, HPV 11 and 16
May progress to invasive SCC
Skin Caner
Fernando Vega, M.D. 8
SCC is locally invasive and destructive
Metastases in 1-3% of casescases
To lymph nodes50-73% survival
Distant sites (lungs)Incurable
Malignant Melanoma
Risk factorsFair skin, red hair, and blue eyes
Intermittent sun exposureSunburnsTanning beds
Freckles and melanocytic nevi
Family history of melanoma
Clinical types- MM
Superficial spreading melanomaSuperficial spreading melanoma
Lentigo maligna melanoma
Acral lentiginous melanomaNodular melanoma
ABCD of Melanoma
Asymmetry
Border irregularityBorder irregularity
Color variegation
Diameter >6mm
Clinical Images of Pigmented Lesions
Tsao H et al. N Engl J Med 2004;351:998-1012
Skin Caner
Fernando Vega, M.D. 9
Biologic Events and Molecular Changes in the Progression of Melanoma
Miller A and Mihm M. N Engl J Med 2006;355:51-65
Benign Melanocytic Neoplasms
Benign Melanocytic Neoplasms
Benign Melanocytic Neoplasms
Benign Melanocytic Neoplasms
Congenital nevus
Skin Caner
Fernando Vega, M.D. 10
Malignant Melanoma Malignant MelanomaWith Regression
Malignant MelanomaSupeerficial Spreading
Malignant Melanoma
Malignant MelanomaCiliary Body
Malignant Melanoma
Skin Caner
Fernando Vega, M.D. 11
Malignant Melanoma Malignant Melanoma
Malignant Melanoma Malignant Melanoma
Malignant Melanoma Malignant Melanoma
Skin Caner
Fernando Vega, M.D. 12
Malignant Melanoma Malignant Melanoma
Malignant Melanoma Malignant Melanoma
Malignant Melanoma LENTIGO MALIGNA
An in situ pattern of malignant melanomaOften reaches a large size before the diagnosis is madeLentigo → lentigo maligna →lentigo maligna melanoma
Skin Caner
Fernando Vega, M.D. 13
CLINICAL FEATURESBegins as a flat pigmented lesion
Usually on sun-yexposed skin of head and neck
With time the colour and border become more irregular
MANAGEMENT Surgery – excision with a wide margin
Radiotherapy
Cryotherapy (deviation from rule)
Immiquimod (by report)
Prognostic features- MMGood prognosis
Breslow < 1mm
Intermediate prognosisBreslow 1-4mm
Bad prognosisBreslow >4mm